Our research group was created in 2010 and now includes three group leaders (Anne Spinewine, Olivia Dalleur and Séverine Henrard). All our group leaders have part time activities in other settings (other research institute or appointment at UCL teaching hospitals). This feature brings a singular dynamic to our group and is a strength to elaborate a sound research group strategy, to reinforce leadership, facilitate development, collaboration and raise funding.
Our research focuses on the epidemiology and the quality of use of medicines in clinical practice, including the detection of inappropriate prescriptions and drug related admissions, and the individualisation of specific drug treatments. In particular, our work focuses on high risk populations (older people, patients with chronic diseases, patients in intensive care), high risk medications (anticoagulants, antibiotics), and high risk situations (polymedication, multimorbidity, acute infections, and patients transiting across settings of care).